Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTHFR C677C/T-guided folic acid + vitamin B12 with different antihypertensive regimens in MHD patients with hypertension and coronary heart disease
ChiCTR2500112318Phase 4Not yet recruiting
- Sponsor
- The Peoples' Hospital of Jiaozuo City
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of folic acid and cyanocobalamin in hypertension (HTN), coronary arteriosclerosis, hyperhomocysteinemia and 1 more (4 arms), sponsored by The Peoples' Hospital of Jiaozuo City. Primary endpoints: Blood pressure during hemodialysis sessions, 24-hour systolic blood pressure average real variability (24h SBP-ARV) and 1 more. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
folic acidcyanocobalamin
03
Conditions
hypertension (HTN)coronary arteriosclerosishyperhomocysteinemiaend-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ChiCTR2500112318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112318.